蓝鸟生物(BLUE)
搜索文档
bluebird bio(BLUE) - 2020 Q3 - Quarterly Report
2020-11-05 05:12
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 __________________________________________________________________ FORM 10-Q __________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Num ...
bluebird bio(BLUE) - 2020 Q2 - Quarterly Report
2020-08-06 04:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 __________________________________________________________________ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share BLUE The NASDAQ Stock Market LLC FORM 10-Q __________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ...
bluebird bio(BLUE) - 2020 Q1 - Earnings Call Transcript
2020-05-12 10:04
bluebird bio, Inc. (NASDAQ:BLUE) Q1 2020 Results Earnings Conference Call May 11, 2020 8:00 AM ET Company Participants Ingrid Goldberg – Vice President-Investor Relations, bluebird bio, Inc. Nick Leschly – Chief Bluebird & Director, bluebird bio, Inc. David M. Davidson – Chief Medical Officer, bluebird bio, Inc. William Denise Baird – Chief Financial Officer, bluebird bio, Inc. Joanne M. Smith-Farrell – Chief Business Officer, bluebird bio, Inc. Alison C. Finger – Chief Commercial Officer, bluebird bio, Inc ...
bluebird bio(BLUE) - 2020 Q1 - Quarterly Report
2020-05-11 19:40
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 __________________________________________________________________ FORM 10-Q __________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: ...